HuagongsheHuagongshe Chemistry Print Report · For research reference only
(2,5-Difluorophenyl)boronic acid → 3-(2,5-Difluorophenyl)-5-(5-methyl-1,3,4-oxadiazol-2-yl)furo[3,2-b]pyridine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (2,5-Difluorophenyl)boronic acid | HCID 2734335 | — |
| Reactant | 3-Bromo-5-(5-methyl-1,3,4-oxadiazol-2-yl)furo[3,2-b]pyridine | HCID 68663099 | — |
| Product | 3-(2,5-Difluorophenyl)-5-(5-methyl-1,3,4-oxadiazol-2-yl)furo[3,2-b]pyridine | HCID 68664109 | 43% |
Reaction Steps
In the same manner as in Example 132 and using 3-bromo-5-(5-methyl-1,3,4-oxadiazol-2-yl)furo[3,2-b]pyridine instead of 2-(3-bromo-1-benzofuran-5-yl)-5-methyl-1,3,4-oxadiazole, using (2,5-difluorophenyl)boronic acid instead of (4-fluorophenyl)boronic acid, and using [1,1′-bis(diphenylphosphino)ferrocene]palladium(II) chloride dichloromethane complex instead of tetrakis(triphenylphosphine)palladium(0), the title compound (yield 43%) was obtained as colorless crystals.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08492378B2 |
| Source dataset | uspto-grants-2013_07 |
| ORD ID | ord-d8a17456381a4020aa07b62976e46c87 |
| Source note | uspto-grants-2013_07 |